Juhlin CC - Search Results

1

Regional differences in somatostatin receptor 2 (SSTR2) immunoreactivity is coupled to level of bowel invasion in small intestinal neuroendocrine tumors.

Fotouhi O, Zedenius J, Höög A, Juhlin CC. Fotouhi O, et al. Among authors: juhlin cc. Neuro Endocrinol Lett. 2018 Oct;39(4):305-309. Neuro Endocrinol Lett. 2018. PMID: 30531706 Free article.

2

Insulin-like growth factor-II in endocrine pancreatic tumours. Immunohistochemical, biochemical and in situ hybridization findings.

Höög A, Kjellman M, Nordqvist AC, Höög CM, Juhlin C, Falkmer S, Schalling M, Grimelius L. Höög A, et al. APMIS. 2001 Feb;109(2):127-40. doi: 10.1034/j.1600-0463.2001.d01-114.x. APMIS. 2001. PMID: 11398994

3

Loss of parafibromin expression in a subset of parathyroid adenomas.

Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, Weber G, Höög A, Villablanca A. Juhlin C, et al. Endocr Relat Cancer. 2006 Jun;13(2):509-23. doi: 10.1677/erc.1.01058. Endocr Relat Cancer. 2006. PMID: 16728578

4

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.

Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenström J, Forsberg L, Bränström R, Obara T, Arnold A, Larsson C, Höög A. Juhlin CC, et al. Endocr Relat Cancer. 2007 Jun;14(2):501-12. doi: 10.1677/ERC-07-0021. Endocr Relat Cancer. 2007. PMID: 17639063

5

Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.

Juhlin CC, Haglund F, Villablanca A, Forsberg L, Sandelin K, Bränström R, Larsson C, Höög A. Juhlin CC, et al. Int J Oncol. 2009 Feb;34(2):481-92. Int J Oncol. 2009. PMID: 19148484

6

Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.

Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenström J, Höög A, Larsson C. Juhlin CC, et al. PLoS One. 2010 Mar 1;5(3):e9472. doi: 10.1371/journal.pone.0009472. PLoS One. 2010. PMID: 20208994 Free PMC article.

7

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

Juhlin CC, Nilsson IL, Johansson K, Haglund F, Villablanca A, Höög A, Larsson C. Juhlin CC, et al. Endocr Pathol. 2010 Sep;21(3):166-77. doi: 10.1007/s12022-010-9121-z. Endocr Pathol. 2010. PMID: 20473645

8

Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas.

Haglund F, Andreasson A, Nilsson IL, Höög A, Larsson C, Juhlin CC. Haglund F, et al. Among authors: juhlin cc. Clin Endocrinol (Oxf). 2010 Oct;73(4):552-3. doi: 10.1111/j.1365-2265.2010.03830.x. Clin Endocrinol (Oxf). 2010. PMID: 20550535 No abstract available.

9

Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma.

Sofiadis A, Dinets A, Orre LM, Branca RM, Juhlin CC, Foukakis T, Wallin G, Höög A, Hulchiy M, Zedenius J, Larsson C, Lehtiö J. Sofiadis A, et al. Among authors: juhlin cc. Thyroid. 2010 Oct;20(10):1067-76. doi: 10.1089/thy.2009.0400. Thyroid. 2010. PMID: 20629554

10

Parafibromin as a diagnostic instrument for parathyroid carcinoma-lone ranger or part of the posse?

Juhlin CC, Höög A. Juhlin CC, et al. Int J Endocrinol. 2010;2010:324964. doi: 10.1155/2010/324964. Epub 2010 Dec 12. Int J Endocrinol. 2010. PMID: 21197463 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters